NCT00789373 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- pemetrexed: 500 mg/m\^2, intravenous (IV), on Day 1 of each 21-day cycle for 4 cycles. cisplatin: 75 mg/m\^2, IV, on Day 1 of each 21-day cycle for 4 cycles.
- id
- FG000
- title
- Induction Pemetrexed + Cisplatin
- description
- Following Induction, received 500 mg/m\^2 maintenance pemetrexed, IV, on Day 1 of each 21-day cycle plus Best Supportive Care until progressive disease (PD) or treatment discontinuation.
- id
- FG001
- title
- Pemetrexed + Cisplatin Followed by Maintenance Pemetrexed
- description
- Following Induction, received placebo (normal saline \[0.9% sodium chloride\]) administered IV on Day 1 of every 21-day cycle plus Best Supportive Care until PD or treatment discontinuation.
- id
- FG002
- title
- Pemetrexed + Cisplatin Followed by Placebo
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 64
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 24
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death Due to study disease
- reasons
- group Id
- FG000
- num Subjects
- 19
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death due to adverse event
- reasons
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death due to toxicity
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death due to procedure
- reasons
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Investigator decision
- reasons
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Protocol entry criteria not met
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 220
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Progressive Disease
- reasons
- group Id
- FG000
- num Subjects
- 37
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Withdrawal by Subject
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 939
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- STARTED
- achievements
- comment
- 1 patient received maintenance therapy post-induction but was never randomized.
- group Id
- FG000
- num Subjects
- 540
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 399
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Induction
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 65
- group Id
- FG002
- num Subjects
- 12
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 3
- group Id
- FG002
- num Subjects
- 1
- type
- Death due to study disease
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 1
- type
- Death due to adverse event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 2
- type
- Death due to toxicity
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 2
- type
- Investigator Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 0
- type
- Protocol entry criteria not met
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 253
- group Id
- FG002
- num Subjects
- 152
- type
- Progressive Disease
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 21
- group Id
- FG002
- num Subjects
- 8
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Sponsor Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 0
- type
- Participants On-Going at Data Cut-Off
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 359
- group Id
- FG002
- num Subjects
- 180
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 359
- group Id
- FG002
- num Subjects
- 180
- type
- NOT COMPLETED
- title
- Maintenance
Complete source fields
- groups
- description
- pemetrexed: 500 mg/m\^2, intravenous (IV), on Day 1 of each 21-day cycle for 4 cycles. cisplatin: 75 mg/m\^2, IV, on Day 1 of each 21-day cycle for 4 cycles.
- id
- FG000
- title
- Induction Pemetrexed + Cisplatin
- description
- Following Induction, received 500 mg/m\^2 maintenance pemetrexed, IV, on Day 1 of each 21-day cycle plus Best Supportive Care until progressive disease (PD) or treatment discontinuation.
- id
- FG001
- title
- Pemetrexed + Cisplatin Followed by Maintenance Pemetrexed
- description
- Following Induction, received placebo (normal saline \[0.9% sodium chloride\]) administered IV on Day 1 of every 21-day cycle plus Best Supportive Care until PD or treatment discontinuation.
- id
- FG002
- title
- Pemetrexed + Cisplatin Followed by Placebo
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 64
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 24
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death Due to study disease
- reasons
- group Id
- FG000
- num Subjects
- 19
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death due to adverse event
- reasons
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death due to toxicity
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Death due to procedure
- reasons
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Investigator decision
- reasons
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Protocol entry criteria not met
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 220
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Progressive Disease
- reasons
- group Id
- FG000
- num Subjects
- 37
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Withdrawal by Subject
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 939
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- STARTED
- achievements
- comment
- 1 patient received maintenance therapy post-induction but was never randomized.
- group Id
- FG000
- num Subjects
- 540
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 399
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Induction
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 65
- group Id
- FG002
- num Subjects
- 12
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 3
- group Id
- FG002
- num Subjects
- 1
- type
- Death due to study disease
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 1
- type
- Death due to adverse event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 2
- type
- Death due to toxicity
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 2
- type
- Investigator Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 0
- type
- Protocol entry criteria not met
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 253
- group Id
- FG002
- num Subjects
- 152
- type
- Progressive Disease
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 21
- group Id
- FG002
- num Subjects
- 8
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Sponsor Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 0
- type
- Participants On-Going at Data Cut-Off
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 359
- group Id
- FG002
- num Subjects
- 180
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 359
- group Id
- FG002
- num Subjects
- 180
- type
- NOT COMPLETED
- title
- Maintenance
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle